Co-infxn

Anaplasma Phagocytophilum, Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (canine), Encephalitis Nosode, Mycoplasma Pneumoniae, Meningococcus Nosode, Hepatitis B Nosode

Deseret Biologicals, Inc.
Human Otc Drug
NDC 43742-1482

Co-infxn also known as Anaplasma Phagocytophilum, Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (canine), Encephalitis Nosode, Mycoplasma Pneumoniae, Meningococcus Nosode, Hepatitis B Nosode is a human otc drug labeled by 'Deseret Biologicals, Inc.'. National Drug Code (NDC) number for Co-infxn is 43742-1482. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Co-infxn drug includes Anaplasma Phagocytophilum - 15 [hp_X]/mL Babesia Microti - 15 [hp_X]/mL Bartonella Henselae - 15 [hp_X]/mL Borrelia Burgdorferi - 15 [hp_X]/mL Ehrlichia Canis - 15 [hp_X]/mL Hepatitis B Virus - 15 [hp_C]/mL Japanese Encephalitis Virus - 15 [hp_X]/mL Mycoplasma Pneumoniae - 15 [hp_X]/mL Neisseria Meningitidis - 21 [hp_X]/mL . The currest status of Co-infxn drug is Active.

Drug Information:

Drug NDC:	43742-1482
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Co-infxn
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Anaplasma Phagocytophilum, Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (canine), Encephalitis Nosode, Mycoplasma Pneumoniae, Meningococcus Nosode, Hepatitis B Nosode
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Deseret Biologicals, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ANAPLASMA PHAGOCYTOPHILUM - 15 [hp_X]/mL BABESIA MICROTI - 15 [hp_X]/mL BARTONELLA HENSELAE - 15 [hp_X]/mL BORRELIA BURGDORFERI - 15 [hp_X]/mL EHRLICHIA CANIS - 15 [hp_X]/mL HEPATITIS B VIRUS - 15 [hp_C]/mL JAPANESE ENCEPHALITIS VIRUS - 15 [hp_X]/mL MYCOPLASMA PNEUMONIAE - 15 [hp_X]/mL NEISSERIA MENINGITIDIS - 21 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	14 May, 2019
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	18 Sep, 2024
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	23 Dec, 2025
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Deseret Biologicals, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	BHE5668847 1948X6KEG3 84PG7W9845 0J8NV9V5Q8 970Y8T1JZY 77H9EM77P7 P07E7XWU9D JQE470FAD0 V3TP2MD7F3
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
43742-1482-1	30 mL in 1 BOTTLE, DROPPER (43742-1482-1)	14 May, 2019	18 Sep, 2024	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Co-infxn

Anaplasma Phagocytophilum & more..

Liquid
Deseret Biologicals, Inc.
NDC: 43742-1482

Purpose:

Homeopathic indications: for the temporarily relief of symptoms related to lyme disease or other co-infections including joint pain, severe headaches, fever, severe muscle aches/pain, flu-like feelings of headache, stiff neck, muscle aches, and change in smell/taste, difficulty chewing, swallowing or speaking, hoarseness of vocal cord problems.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

Product Elements:

Co-infxn anaplasma phagocytophilum, babesia microti, bartonella henselae, borrelia burgdorferi nosode, ehrlichia nosode (canine), encephalitis nosode, mycoplasma pneumoniae, meningococcus nosode, hepatitis b nosode anaplasma phagocytophilum anaplasma phagocytophilum babesia microti babesia microti bartonella henselae bartonella henselae borrelia burgdorferi borrelia burgdorferi ehrlichia canis ehrlichia canis japanese encephalitis virus japanese encephalitis virus mycoplasma pneumoniae mycoplasma pneumoniae neisseria meningitidis neisseria meningitidis hepatitis b virus hepatitis b virus water alcohol

Indications and Usage:

Warnings:

Warnings: keep out of reach of children. in case of overdose, contact a physician or poison control center right away. if pregnant or breast-feeding, seek advice of a health professional before use. tamper seal: "sealed for your protection." do not use if seal is broken or missing.

Dosage and Administration:

Directions: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Package label display: des bio ndc 43742-1482-1 homeopathic co-infxn 1 fl oz (30 ml) co-infxn

Further Questions:

Questions: dist. by: deseret biologicals, inc. 469 w. parkland drive sandy, ut 84070 www.desbio.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.